593287-07-1

Upstream product

• 19227-13-5 (Z)-N'-hydroxy-4-methylbenzimidamide 
• 4397-55-1 phthalic monoacid monomethyl ester chloride 
• 4376-18-5 Monomethyl phthalate 
• 104-85-8 para-methylbenzonitrile 

Downstream Products

• 593287-08-2 methyl 2-[5-[4-(bromomethyl)phenyl]-1,2,4-oxadiazol-3-yl]benzoate 
• 593287-11-7 methyl 2-{3-[4-(2-propyl-1H-benzimidazol-1-ylmethyl)phenyl]-1,2,4-oxadiazol-5-yl}benzoate 
• 593287-23-1 methyl 2-{3-[4-(2,7,8-trimethylquinolin-4-yloxymethyl)phenyl]-1,2,4-oxadiazol-5-yl}benzoate 
• 593287-21-9 ethyl 4-{4-[5-(2-carbomethoxyphenyl)-1,2,4-oxadiazol-3-yl]benzyloxy}-2-methyl-quinoline-6-carboxylate 
• 593287-22-0 ethyl 4-{4-[5-(2-carbomethoxyphenyl)-1,2,4-oxadiazol-3-yl]benzyloxy}-2-ethyl-quinoline-6-carboxylate 

Relevant academic research and scientific papers

Synthesis of new 1,2,4- and 1,3,4-oxadiazole derivatives

A novel series of compounds structurally related to non-peptide angiotensin II (AII) receptor antagonists has been prepared. In these compounds, the 'spacer' phenyl ring commonly found in almost all AII receptor antagonists was replaced by 1,2,4- and 1,3,

Oxadiazolyl benzamides

Substituted or unsubstituted oxadiazolyl benzamides, e.g., o-(3-phenyl-1,2,4-oxadiazol-5-yl)-N-methyl-benzamide, are prepared by reacting a corresponding substituted or unsubstituted oxadiazoyl benzoic acid alkyl ester with an amine and are useful as minor tranquilizers and sleep inducers.